CompoAtlas

Mix Fibres

Food supplement declared in France, declaration No 2022-3-1054

Mix Fibres (Fleurance Nature) is a food supplement declared in France. Status: retiré du marché le 1 July 2025. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Fleurance Nature
Food business operator placing the product on the market
Fleurance Nature
Status
Retiré du marché le 1 July 2025
Form
Sachet
Daily dose
15 g (2 cuillères à soupe)
Directions for use
Prendre 2 cuillères à soupe par jour (soit environ 15 g/jour)
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement médicamenteux
Objectives stated by the manufacturer (these are not authorised claims)
Transit
Flavourings
Aucun

Declaration 183066, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Cichorium intybus L.RacinePoudre (de plantes séchées ou broyées)5.7 g
Linum usitatissimum L.GrainePoudre (de plantes séchées ou broyées)5.7 g
Plantago ovata Forssk.TégumentPoudre (de plantes séchées ou broyées)3.4 g

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et d'un régime alimentaire varié et équilibré. Tenir hors de portée des enfants. Respecter les doses conseillées. Déconseillé aux femmes enceintes ou allaitantes et aux enfants de moins de 12 ans. Déconseillé aux femmes ayant des antécédents personnels ou familiaux de cancer du sein. Déconseillé en cas de prise concomitante de médicaments. Bien refermer le sachet après ouverture. A conserver à l'abri de l'humidité, de la lumière et de la chaleur.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Linum usitatissimum L.
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Fleurance Nature

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.